Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Prostatic Neoplasms, Date of authorisation: 26/04/2021, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Prostatic Neoplasms, Date of authorisation: 26/04/2021, Status: Authorised
[automaticbacklinks]